Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Plantar Stimulation, Whole-Body Vibration, and Baduanjin for Muscle Activation

9. September 2026 aktualisiert von: Nanfang Hospital, Southern Medical University

Study on the Activation Effect of Vibration Training Under Plantar Stimulation and Baduanjin on Lower Limb Muscles

This study will examine how different short-term exercise and vibration conditions affect lower-limb muscle activity in young adults with flat feet and young adults with normal feet.

Participants will complete several conditions, including whole-body vibration, whole-body vibration combined with plantar stimulation under different areas of the foot, and a Baduanjin heel-raise exercise. Surface electromyography sensors will be placed on the skin over selected lower-limb muscles to record muscle activity before and during each condition. Each participant will complete all study conditions in a balanced order.

This study does not aim to treat flat feet or evaluate long-term clinical benefits. The purpose is to collect preliminary information on immediate muscle activation and foot discomfort, which may help design future studies on foot-related exercise, plantar stimulation, and rehabilitation training.

Studienübersicht

Detaillierte Beschreibung

This is a prospective, exploratory, self-controlled crossover study designed to investigate the immediate effects of different exercise and vibration-based conditions on lower-limb muscle activation.

Flat feet may be associated not only with structural changes of the foot arch, but also with altered neuromuscular control of the lower limb. Whole-body vibration provides a standardized mechanical stimulus, while Baduanjin heel-raise exercise represents an active movement-based training condition. Because the plantar surface is an important sensory input area, this study will also examine whether adding regional plantar stimulation to whole-body vibration produces different muscle activation patterns compared with whole-body vibration alone.

Participants will be classified as having flat feet or normal feet based on foot type assessment. Each participant will complete all study conditions in a balanced order, including whole-body vibration alone, whole-body vibration combined with stimulation of different plantar regions, and Baduanjin heel-raise exercise. Surface electromyography will be used to record lower-limb muscle activity before and during each condition.

This study is not designed to evaluate treatment efficacy or long-term clinical outcomes. Its purpose is to collect preliminary mechanistic data on immediate neuromuscular responses, which may inform future studies on plantar stimulation, vibration training, and individualized rehabilitation strategies.

Studientyp

Interventionell

Einschreibung (Geschätzt)

30

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienkontakt

Studienorte

    • Guangdong
      • Guangzhou, Guangdong, China, 510515
        • Rekrutierung
        • Nanfang Hospital, Southern Medical University
        • Hauptermittler:
          • chao chen, PhD
        • Kontakt:
          • YiJian Li, PhD
          • Telefonnummer: +86-20-62787238
          • E-Mail: nfyyec@163.com

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

  • Erwachsene

Akzeptiert gesunde Freiwillige

Ja

Beschreibung

Inclusion Criteria:

  1. College students aged 18 to 25, regardless of gender
  2. agree to participate in the study and voluntarily sign the informed consent form
  3. and are deemed suitable to participate in this study by the researchers.

Exclusion Criteria:

  1. Persons with severe cardiovascular diseases, motor dysfunction or cognitive disorders
  2. persons who have suffered severe trauma or been hospitalized recently and are unsuitable for exercise testing
  3. persons with congenital lower limb or spinal deformities affecting foot posture other than flatfoot
  4. persons with a medical history of muscular, neurological or skeletal system disorders affecting foot posture other than flatfoot
  5. persons deemed ineligible to participate in this study by the investigators

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Sonstiges
  • Zuteilung: Nicht randomisiert
  • Interventionsmodell: Crossover-Aufgabe
  • Maskierung: Keine (Offenes Etikett)

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: Flatfoot Group

Participants will complete three types of study conditions. In the whole-body vibration (WBV) condition, they will stand barefoot at the center of the vibration platform with feet about 20 cm apart, knees flexed at 20°-25°, arms relaxed, head and neck neutral, eyes forward, and body weight evenly distributed. WBV will be delivered at 20 Hz and 2 mm for 60 seconds.

For WBV plus regional plantar stimulation, the same posture and WBV parameters will be used. A plantar stimulation module will be placed on the platform, and participants will position the assigned plantar region on the module. Four regions will be stimulated separately: toe region, metatarsal head region, medial plantar/tibial-side region, and lateral plantar/fibular-side region. Each condition will last 60 seconds.

For the Baduanjin condition, participants will perform the "Bei Hou Qi Dian Bai Bing Xiao" heel-raise movement under professional guidance, with 6 repetitions completed within 60 seconds.

Participants will complete three types of intervention conditions. In the whole-body vibration condition, participants will stand barefoot on a vibration platform with feet about 20 cm apart and knees flexed at 20°-25°. Vibration will be delivered at 20 Hz and 2 mm for 60 seconds. In the whole-body vibration with regional plantar stimulation condition, the same vibration parameters and posture will be used, while a plantar stimulation module is placed on the platform. Four plantar regions will be stimulated separately: the toe region, metatarsal head region, medial plantar region, and lateral plantar region. In the Baduanjin condition, participants will perform a heel-raise movement derived from Baduanjin under professional guidance, completing six repetitions within 60 seconds.
Aktiver Komparator: Normal Foot Group

Participants will complete three types of study conditions. In the whole-body vibration (WBV) condition, they will stand barefoot at the center of the vibration platform with feet about 20 cm apart, knees flexed at 20°-25°, arms relaxed, head and neck neutral, eyes forward, and body weight evenly distributed. WBV will be delivered at 20 Hz and 2 mm for 60 seconds.

For WBV plus regional plantar stimulation, the same posture and WBV parameters will be used. A plantar stimulation module will be placed on the platform, and participants will position the assigned plantar region on the module. Four regions will be stimulated separately: toe region, metatarsal head region, medial plantar/tibial-side region, and lateral plantar/fibular-side region. Each condition will last 60 seconds.

For the Baduanjin condition, participants will perform the "Bei Hou Qi Dian Bai Bing Xiao" heel-raise movement under professional guidance, with 6 repetitions completed within 60 seconds.

Participants will complete three types of intervention conditions. In the whole-body vibration condition, participants will stand barefoot on a vibration platform with feet about 20 cm apart and knees flexed at 20°-25°. Vibration will be delivered at 20 Hz and 2 mm for 60 seconds. In the whole-body vibration with regional plantar stimulation condition, the same vibration parameters and posture will be used, while a plantar stimulation module is placed on the platform. Four plantar regions will be stimulated separately: the toe region, metatarsal head region, medial plantar region, and lateral plantar region. In the Baduanjin condition, participants will perform a heel-raise movement derived from Baduanjin under professional guidance, completing six repetitions within 60 seconds.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Root Mean Square Value
Zeitfenster: Day 1: from the resting baseline immediately before each intervention condition through completion of that intervention condition.
Electrodes were placed per SENIAM standards (2000 Hz sampling, 20-450 Hz band-pass and 50 Hz band-stop filtering). Data were collected during a 30 s resting baseline and the 30-60 s stable phase of intervention. After offline full-wave rectification, RMS was calculated using a 200 ms sliding window (100 ms step). Mean RMS within each epoch was adopted as the representative value.
Day 1: from the resting baseline immediately before each intervention condition through completion of that intervention condition.

Andere Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Integrated Electromyography
Zeitfenster: Day 1: from the resting baseline immediately before each intervention condition through completion of that intervention condition.
discharge during the resting baseline phase (stable signals for 60 consecutive seconds) before each intervention mode and the entire intervention period (60 seconds) during intervention, namely the area under the curve of electromyographic signals after full-wave rectification, which reflects the overall activation level.
Day 1: from the resting baseline immediately before each intervention condition through completion of that intervention condition.

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Ermittler

  • Hauptermittler: chao chen, PhD, Nanfang Hospital, Southern Medical University

Publikationen und hilfreiche Links

Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Geschätzt)

1. September 2026

Primärer Abschluss (Geschätzt)

1. Mai 2027

Studienabschluss (Geschätzt)

1. Mai 2027

Studienanmeldedaten

Zuerst eingereicht

2. September 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

9. September 2026

Zuerst gepostet (Tatsächlich)

10. September 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

10. September 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

9. September 2026

Zuletzt verifiziert

1. September 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

NEIN

Beschreibung des IPD-Plans

Individual-participant data will not be shared publicly due to participant privacy protection requirements, and the informed consent does not include provisions for open data sharing.

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Abonnieren